Nisa Investment Advisors’s Achillion Pharmaceuticals ACHN Stock Holding History

Nisa Investment Advisors’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,700	Closed	-$16K	–	2188
2019 Q4	$16K	Hold	2,700	–	–	﹤0.01%	1740
2019 Q3	$10K	Hold	2,700	–	–	﹤0.01%	1796
2019 Q2	$7K	Hold	2,700	–	–	﹤0.01%	1850
2019 Q1	$8K	Buy	+2,700	New	+$6.63K	﹤0.01%	1836
2016 Q4	–	Sell	-2,300	Closed	-$19K	–	1916
2016 Q3	$19K	Hold	2,300	–	–	﹤0.01%	1675
2016 Q2	$18K	Hold	2,300	–	–	﹤0.01%	1660
2016 Q1	$18K	Buy	+2,300	New	+$16.8K	﹤0.01%	1649
2014 Q2	–	Sell	-11,200	Closed	-$37K	–	1335
2014 Q1	$37K	Buy	+11,200	New	+$39.2K	﹤0.01%	1320

Nisa Investment Advisors's ACHN Position: Q1 2020 in Review

Nisa Investment Advisors sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 2,700 shares — an estimated $16K sold.

Nisa Investment Advisors first reported a position in ACHN in Q1 2014 and held it in 8 quarters. The position peaked at $37K in Q1 2014. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Nisa Investment Advisors reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Nisa Investment Advisors sold 2,700 Achillion Pharmaceuticals shares in Q1 2020, an estimated $16K.
Nisa Investment Advisors first reported a position in Achillion Pharmaceuticals in Q1 2014 and held it in 8 quarters.
Nisa Investment Advisors's Achillion Pharmaceuticals position peaked at $37K in Q1 2014.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Nisa Investment Advisors's 13F filing for Q1 2020, filed 17 Apr 2020.